Firebrick Pharma Limited engages in the development and partnering of broad-spectrum antimicrobial spray for the treatment of common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.
Stock data | 2025 | Change |
---|---|---|
Price | $0.033630401883302505 | N/A |
Market Cap | $5.99M | N/A |
Shares Outstanding | 178.05M | N/A |
Employees | 0 | N/A |